#154271

Anti-Timeless

Cat. #154271

Anti-Timeless

Cat. #: 154271

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Timeless

Class: Polyclonal

Application: ChIP ; IF ; WB

Reactivity: Human

Host: Rabbit

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Eishi Noguchi

Institute: Drexel University

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Timeless
  • Research fields: Cell biology;Cell signaling and signal transduction;Genetics
  • Tool sub type: Primary antibody
  • Class: Polyclonal
  • Conjugation: Unconjugated
  • Molecular weight: 139 kDa
  • Reactivity: Human
  • Host: Rabbit
  • Application: ChIP ; IF ; WB
  • Description: Rabbit polyclonal antibody that recognizes the c-terminal region (914-1208) of human Timeless
  • Immunogen: GST-Timeless (914-1208)
  • Immunogen uniprot id: TIM_HUMAN

Target Details

  • Target: Timeless
  • Molecular weight: 139 kDa
  • Target background: Rabbit polyclonal antibody that recognizes the c-terminal region (914-1208) of human Timeless

Applications

  • Application: ChIP ; IF ; WB

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • Leman et al. 2010. J Cell Sci. 123(Pt 5):660-70. PMID: 20124417.
  • Human Timeless and Tipin stabilize replication forks and facilitate sister-chromatid cohesion.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.